|
LSM11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.373199999961E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.94309999995901E-06 |
| Normal-vs-Stage2 |
1.62487999999517E-05 |
| Normal-vs-Stage3 |
2.07429999999897E-05 |
| Normal-vs-Stage4 |
3.205800E-04 |
| Stage1-vs-Stage2 |
3.213000E-01 |
| Stage1-vs-Stage3 |
9.782400E-01 |
| Stage1-vs-Stage4 |
5.471200E-01 |
| Stage2-vs-Stage3 |
3.740400E-01 |
| Stage2-vs-Stage4 |
1.893770E-01 |
| Stage3-vs-Stage4 |
5.629600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.95139999995087E-06 |
| Normal-vs-AfricanAmerican |
3.264000E-02 |
| Normal-vs-Asian |
2.220500E-03 |
| Caucasian-vs-AfricanAmerican |
2.023600E-01 |
| Caucasian-vs-Asian |
1.971600E-01 |
| AfricanAmerican-vs-Asian |
7.858400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47520000004508E-06 |
| Normal-vs-Female |
4.76140000005287E-06 |
| Male-vs-Female |
3.601800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.43569999999194E-05 |
| Normal-vs-Age(41-60Yrs) |
3.8556000000467E-06 |
| Normal-vs-Age(61-80Yrs) |
2.424599999995E-06 |
| Normal-vs-Age(81-100Yrs) |
5.258000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.385000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.454400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.348400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.281200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.593800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.199200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.749200E-01 |
| Classical-VS-Follicular |
5.12970000032809E-07 |
| Classical-VS-Other |
9.184400E-02 |
| Classical-VS-Normal |
2.757500E-04 |
| Tall-VS-Follicular |
2.275700E-02 |
| Tall-VS-Other |
2.209600E-01 |
| Tall-VS-Normal |
1.224430E-03 |
| Follicular-VS-Other |
9.802000E-01 |
| Follicular-VS-Normal |
7.19630000034499E-09 |
| Other-VS-Normal |
9.360500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.47959999982928E-07 |
| Normal-vs-N1 |
8.42430000000949E-05 |
| N0-vs-N1 |
4.782200E-01 |
|
|
